TABLE 8.
Method | Start | End | Peptide | Length (aa)a | Allergenicity |
---|---|---|---|---|---|
BepiPred linear epitope prediction | 66 | 77 | SGPQGANSQSSV | 12 | Nonallergen |
404 | 417 | AREGDVQEPAWSPY | 14 | Allergen | |
Chou and Fasman beta turn prediction | 194 | 200 | SWSPNGK | 7 | Nonallergen |
294 | 300 | SGRGGSP | 7 | Nonallergen | |
Emini surface accessibility prediction | 206 | 212 | SFEKKKA | 7 | Nonallergen |
277 | 287 | IDTEPRYSPDG | 11 | Nonallergen | |
Karplus and Schulz flexibility prediction | 160 | 166 | QRNGGRS | 7 | Allergen |
308 | 314 | ADGQISR | 7 | Nonallergen | |
Kolaskar and Tongaonkar antigenicity scale | 5 | 23 | IISLFLLLFTGQVIALDLE | 19 | Nonallergen |
243 | 252 | GQHLAVVLSK | 10 | Nonallergen | |
Parker hydrophilicity prediction | 174 | 180 | DADGHNP | 7 | Allergen |
283 | 289 | YSPDGRS | 7 | Nonallergen |
aa, amino acids.